Oxford Biosystems
  • News

    News from Oxford BioSystems

    News from Oxford BioSystems
01Apr

Oxford BioSystems is proud to be an Antibiotic Guardian

Oxford BioSystems is proud to be an Antibiotic Guardian organisation, supporting the UK’s efforts to tackle antimicrobial resistance (AMR) and protect the effectiveness of antibiotics for future generations.

Antimicrobial resistance, including antibiotic resistance, is one of the most significant global health challenges. Addressing it requires collaboration across research, healthcare, diagnostics and public health.

Why Antimicrobial Resistance Matters

Without effective antibiotics, many modern medical treatments become significantly more risky. Routine procedures such as surgery, cancer treatments and the management of infections all rely on antibiotics that work. Scientific research, laboratory diagnostics and innovation also play a critical role in understanding and combating antimicrobial resistance.

Supporting the Antibiotic Guardian Initiative

The Antibiotic Guardian campaign was originally launched in 2014 by Public Health England and is now supported by the UK Health Security Agency, alongside partners across healthcare, research and government.

The initiative encourages organisations and individuals to pledge to support responsible antibiotic use and raise awareness of antimicrobial resistance.

Our Commitment at Oxford BioSystems

As Antibiotic Guardians, we are committed to supporting the scientific community in addressing antimicrobial resistance through:

  • Supporting research into infectious diseases and antimicrobial resistance
  • Providing tools and technologies that enable life science and diagnostic research
  • Raising awareness of the importance of responsible antibiotic use
  • Encouraging our colleagues, partners and customers to become Antibiotic Guardians

You can learn more about the initiative and make your pledge here: https://antibioticguardian.com/

Together, through research, collaboration and awareness, we can help safeguard antibiotics for the future.

About the Author

Related

Using blood biomarkers to study the link between Alzheimer’s disease and Obesity

Using blood biomarkers to study the link between Alzheimer’s disease and Obesity

Biomedical Scientist recently published ‘A preventative approach for Alzheimer’s’, which explores...

Read More >
Bone Metabolism Biomarkers for UK & Irish Laboratories | Oxford BioSystems at Mellanby 2026

Bone Metabolism Biomarkers for UK & Irish Laboratories | Oxford BioSystems at Mellanby 2026

We are delighted to announce that Oxford BioSystems will be returning to the 15th Annual Mellanby Re...

Read More >
How Multiplex ELISAs Are Transforming Biomarker Research | Q-View™ Imager Loan Programme

How Multiplex ELISAs Are Transforming Biomarker Research | Q-View™ Imager Loan Programme

At Oxford BioSystems we’ve observed that biomedical research increasingly relies on analysing multi...

Read More >
Insights: AID Readers and the Updated Benefits

Insights: AID Readers and the Updated Benefits

We recently caught up with Scott Hill, our Technical Services Lead and AID Product Specialist at Oxf...

Read More >
Oxford Biosystems Ltd has moved!

Oxford Biosystems Ltd has moved!

Milton Park is a science, technology and business park situated to the south of Oxford. It is home t...

Read More >
Oxford Biosystems Celebrates 25 Years

Oxford Biosystems Celebrates 25 Years

The official flower for a 25th anniversary is the iris, and it is also recognized as the birth flowe...

Read More >

Categories

Bridging Science and Diagnostics: Over 25 years supplying UK and Irish labs with innovative products from leading global manufacturers

Memberships

Contact Us

+44 (0)1235 431390 sales@oxfordbiosystems.com 180 D/E Park Drive, Milton Park,
Abingdon OX14 4SE